联盛化学 (301212.SZ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	703.0M	693.4M	632.5M	662.0M	1.0B
Cost of Revenue	614.6M	612.8M	568.0M	535.7M	788.9M
Gross Profit	88.5M	80.6M	64.5M	126.3M	252.3M
Operating Expenses
R&D Expense	27.4M	25.1M	20.4M	25.6M	32.9M
SG&A Expense	—	—	—	—	—
General & Admin Expense	38.1M	33.1M	28.3M	32.3M	30.1M
Selling & Marketing Expense	9.4M	9.1M	7.6M	9.3M	10.9M
Other Expenses	—	—	—	—	—
Total Operating Expenses	80.2M	69.5M	47.1M	48.8M	32.9M
Cost and Expenses	694.7M	682.3M	615.1M	584.5M	821.8M
Operating Income (EBIT)	12.3M	17.7M	18.5M	82.2M	221.2M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	11.9M	17.3M	17.6M	82.2M	218.7M
Income Tax Expense	(43.5K)	886.2K	2.2M	10.5M	27.6M
Bottom Line
Net Income	8.8M	13.9M	17.3M	71.1M	183.0M
Earnings from Cont. Ops	11.9M	16.4M	15.4M	71.8M	191.2M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	8.8M	13.9M	17.3M	71.1M	183.0M
Per Share
Basic EPS	CN¥0.09	CN¥0.13	CN¥0.16	CN¥0.66	CN¥1.85
Diluted EPS	CN¥0.09	CN¥0.13	CN¥0.16	CN¥0.66	CN¥1.85
Revenue Per Share	CN¥6.93	CN¥6.51	CN¥5.86	CN¥6.14	CN¥10.53
Shares
Basic Shares Outstanding	101.5M	106.6M	107.9M	107.7M	98.9M
Diluted Shares Outstanding	101.5M	106.6M	107.9M	107.7M	98.9M
Profitability Metrics
EBITDA	—	61.1M	53.0M	112.3M	252.1M
D&A	—	43.3M	34.6M	30.0M	31.0M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026